We Need Your Voice
Send these letters to your elected officials
The National Institutes of Health (NIH) recently announced a new policy for indirect cost reimbursement for research grants that could threaten to have a devastating impact on current and future cancer research in the country. Tell the President to keep cancer research a priority.
New diagnostic technology is beginning to emerge that has the potential to identify cancer signals earlier. Contact your representatives now so when these diagnostics are approved by the FDA, Congress can ensure vulnerable populations have equitable access.
Share our letter to urge your representatives to increase funding for vital research into ovarian and related gynecologic cancers.
Sign up for our Action Alert mailing list so that you can stay up to date on our latest advocacy activities.
A new article from Patient Power highlights findings from a paper authored by Ovarian Cancer Research Alliance (OCRA) and Komodo Health, that reveals significant gaps in genetic testing for ovarian … Continued
Get email updates about research news, action alerts, and ways to join the fight.
